Monte Rosa Therapeutics Inc (GLUE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2022 | 12-2021 | 09-2021 | 06-2021 | 03-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 138,305 | 346,071 | 367,034 | 357,060 | 0 |
| Marketable Securities | 178,858 | N/A | N/A | N/A | 0 |
| TOTAL | $320,366 | $348,666 | $370,519 | $358,289 | $0 |
| Non-Current Assets | |||||
| PPE Net | 13,396 | 12,325 | 11,801 | 8,923 | N/A |
| Other Non-Current Assets | 12,243 | 5,338 | 1,729 | 1,729 | 0 |
| TOTAL | $25,639 | $17,663 | $13,530 | $10,652 | $N/A |
| Total Assets | $346,005 | $366,329 | $384,049 | $368,941 | $0 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 4,511 | 6,558 | 3,530 | 7,463 | 0 |
| Accrued Expenses | 6,455 | 10,080 | 9,213 | 3,328 | 0 |
| TOTAL | $12,490 | $16,638 | $12,743 | $10,791 | $0 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 5,457 | 0 | 0 | 0 | 0 |
| TOTAL | $7,640 | $2,176 | $2,001 | $1,472 | $N/A |
| Total Liabilities | $20,130 | $18,814 | $14,744 | $12,263 | $0 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 46,668 | 46,630 | 46,506 | 46,382 | N/A |
| Common Shares | 5 | 5 | 5 | 4 | 0 |
| Retained earnings | -145,967 | -122,035 | -98,595 | -78,758 | 0 |
| Other shareholders' equity | -2,133 | -2,021 | -1,950 | -1,415 | 0 |
| TOTAL | $325,875 | $347,515 | $369,305 | $356,678 | $0 |
| Total Liabilities And Equity | $346,005 | $366,329 | $384,049 | $368,941 | $0 |